Keith I.K.I.BlockKeith I.K.I., Antineoplastons and the Challenges of Research in Integrative Care, „Integrative Cancer Therapies”, 3 (1), 2004, s. 3–4, DOI: 10.1177/1534735404263274, PMID: 15035867.
EliotE.MarshallEliotE., The politics of alternative medicine, „Science”, 265 (5181), 1994, s. 2000-2002, DOI: 10.1126/science.8091220.
J CJ.C.BucknerJ CJ.C. i inni, Phase II study of antineoplastons A10 (NSC 648539) and AS2-1 (NSC 620261) in patients with recurrent glioma, „Mayo Clinic Proceedings”, 74 (2) pmid=10069350, 1999, s. 137–45, DOI: 10.4065/74.2.137.
Stanislaw R.S.R.BurzynskiStanislaw R.S.R. i inni, The response and survival of children with recurrent diffuse intrinsic pontine glioma based on phase II study of antineoplastons A10 and AS2-1 in patients with brainstem glioma, „Child's Nervous System”, 30 (12), 2014, s. 2051–2061, DOI: 10.1007/s00381-014-2401-z, PMID: 24718705, PMCID: PMC4223571(ang.).
Tai-TongT.T.WongTai-TongT.T., Comment to the paper "The response and survival of children with recurrent diffuse intrinsic pontine glioma based on phase II study of antineoplastons A10 and AS2-1 in patients with brain stem glioma" by Burzynski et al, „Child's Nervous System”, 30 (12), 2014, s. 2069–2070, DOI: 10.1007/s00381-014-2515-3, PMID: 25142686 [dostęp 2023-01-18](ang.).
RobertR.BlaskiewiczRobertR., Comment to the paper: The response and survival of children with recurrent diffuse intrinsic pontine glioma based on phase II study of antineoplastons A10 and AS2-1 in patients with brainstem glioma : Stanislaw R. Burzynski, Tomasz J. Janicki, Gregory S. Burzynski, Ania Marszalek, „Child's Nervous System”, 30 (12), 2014, s. 2067–2068, DOI: 10.1007/s00381-014-2514-4, PMID: 25146834 [dostęp 2023-01-18](ang.).
GiorgioG.PerilongoGiorgioG., Commentary on: "The response and survival of children with recurrent diffuse intrinsic pontine glioma based on phase II study of antineoplastons A10 and AS2-1 in patients with brainstem glioma." By Burzynski et al, „Child's Nervous System”, 30 (12), 2014, s. 2071–2072, DOI: 10.1007/s00381-014-2557-6, PMID: 25330863 [dostęp 2023-01-18](ang.).
MauraM.MassiminoMauraM., Carlo AlfredoC.A.ClericiCarlo AlfredoC.A., Commentary: The response and survival of children with recurrent diffuse intrisic pontine glioma based on phase II study of antineoplastons A10 and AS2-1 in patients with brainstem glioma, by Burzynski G, et al, „Child's Nervous System”, 30 (12), 2014, s. 2065–2066, DOI: 10.1007/s00381-014-2511-7, PMID: 25079885 [dostęp 2023-01-18](ang.).
Keith I.K.I.BlockKeith I.K.I., Antineoplastons and the Challenges of Research in Integrative Care, „Integrative Cancer Therapies”, 3 (1), 2004, s. 3–4, DOI: 10.1177/1534735404263274, PMID: 15035867.
SRS.BurzynskiSRS., Antineoplastons: history of the research (I), „Drugs under experimental and clinical research”, 12 (Suppl 1), 1986, s. 1–9, PMID: 3527634.
Stanislaw R.S.R.BurzynskiStanislaw R.S.R. i inni, The response and survival of children with recurrent diffuse intrinsic pontine glioma based on phase II study of antineoplastons A10 and AS2-1 in patients with brainstem glioma, „Child's Nervous System”, 30 (12), 2014, s. 2051–2061, DOI: 10.1007/s00381-014-2401-z, PMID: 24718705, PMCID: PMC4223571(ang.).
Tai-TongT.T.WongTai-TongT.T., Comment to the paper "The response and survival of children with recurrent diffuse intrinsic pontine glioma based on phase II study of antineoplastons A10 and AS2-1 in patients with brain stem glioma" by Burzynski et al, „Child's Nervous System”, 30 (12), 2014, s. 2069–2070, DOI: 10.1007/s00381-014-2515-3, PMID: 25142686 [dostęp 2023-01-18](ang.).
RobertR.BlaskiewiczRobertR., Comment to the paper: The response and survival of children with recurrent diffuse intrinsic pontine glioma based on phase II study of antineoplastons A10 and AS2-1 in patients with brainstem glioma : Stanislaw R. Burzynski, Tomasz J. Janicki, Gregory S. Burzynski, Ania Marszalek, „Child's Nervous System”, 30 (12), 2014, s. 2067–2068, DOI: 10.1007/s00381-014-2514-4, PMID: 25146834 [dostęp 2023-01-18](ang.).
GiorgioG.PerilongoGiorgioG., Commentary on: "The response and survival of children with recurrent diffuse intrinsic pontine glioma based on phase II study of antineoplastons A10 and AS2-1 in patients with brainstem glioma." By Burzynski et al, „Child's Nervous System”, 30 (12), 2014, s. 2071–2072, DOI: 10.1007/s00381-014-2557-6, PMID: 25330863 [dostęp 2023-01-18](ang.).
MauraM.MassiminoMauraM., Carlo AlfredoC.A.ClericiCarlo AlfredoC.A., Commentary: The response and survival of children with recurrent diffuse intrisic pontine glioma based on phase II study of antineoplastons A10 and AS2-1 in patients with brainstem glioma, by Burzynski G, et al, „Child's Nervous System”, 30 (12), 2014, s. 2065–2066, DOI: 10.1007/s00381-014-2511-7, PMID: 25079885 [dostęp 2023-01-18](ang.).